Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept Study for Preemptive Treatment With Grazoprevir and Elbasvir in Donor HCV-positive to Recipient HCV-negative Cardiac Transplant

NCT03026023 is registered in ClinicalTrials.gov with Raymond T. Chung, MD as lead sponsor.

NCT NCT03026023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03026023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept Study for Preemptive Treatment With Grazoprevir and Elbasvir in Donor HCV-positive to Recipient HCV-negative Cardiac Transplant
Lead sponsor
Raymond T. Chung, MD
Phase
Phase 4
Overall status
Withdrawn
Start date
August 1, 2018
Completion date
June 30, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac transplant disorder, hepatitis c